Comparative Bioavailability of Intranasal Epinephrine

Clinical trial NCT06205134 · COMPLETED

Trial details

NCT number: NCT06205134
Sponsor: Nasus Pharma
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Anaphylaxis Anaphylactic Reaction

Start date: 2023-08-22
Primary completion: 2024-02-02
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.